Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Abecedin is a multivitamin and mineral supplement developed by Napp and manufactured/marketed by Birzeit Pharmaceutical. It is formulated to prevent and treat vitamin and mineral deficiencies, particularly during pregnancy, lactation, old age, or periods of inadequate nutritional intake. The formulation typically contains essential vitamins such as Vitamin A, Vitamin B1 (thiamine), Vitamin B2 (riboflavin), Vitamin B3 (nicotinamide), Vitamin B6 (pyridoxine), Vitamin B9 (folic acid), Vitamin B12 (cyanocobalamin), Vitamin C (ascorbic acid), Vitamin D3 (cholecalciferol), Vitamin E, and Biotin, along with essential minerals including calcium, iron, magnesium, iodine, manganese, and phosphorus. It is available in oral dosage forms such as tablets and oral drops.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Abecedin.